HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Role of Slit-Robo signaling in the proliferation of human mucoepidermoid carcinoma Mc3 cells].

AbstractOBJECTIVE:
To study the role of Slit-Robo signaling in the proliferation of human mucoepidermoid carcinoma Mc3 cells.
METHODS:
We measured the expressions of Slit2 and Robo1 proteins in human mucoepidermoid carcinoma Mc3 cells using immunohistochemistry and flow cytometry. To test the role of Slit-Robo signaling in the proliferation of the cells, we treated the cells with the monoclonal antibody R5 against Robo1 receptor extracellular domain and observed the changes in the cell proliferation by cell counting and colonogenic assay; the expression of proliferating cell nuclear antigen (PCNA) in the cells following the treatment was measured with flow cytometry.
RESULTS:
Treatment of Mc3 cells with the monoclonal antibody R5 caused significantly suppressed cell growth and proliferation and obviously lowered the expression of PCNA.
CONCLUSION:
Slit-Robo signaling can suppress the proliferation of Mc3 cells possibly by up-regulating the expression of PCNA.
AuthorsBing Han, Lijing Wang, Jing Wang, Jie Zhang, Yuan Zhao, Cuiling Qi
JournalNan fang yi ke da xue xue bao = Journal of Southern Medical University (Nan Fang Yi Ke Da Xue Xue Bao) Vol. 32 Issue 1 Pg. 37-9 (Jan 2012) ISSN: 1673-4254 [Print] China
PMID22366001 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Intercellular Signaling Peptides and Proteins
  • Nerve Tissue Proteins
  • Proliferating Cell Nuclear Antigen
  • Receptors, Immunologic
  • roundabout protein
  • Slit homolog 2 protein
Topics
  • Carcinoma, Mucoepidermoid (pathology)
  • Cell Line, Tumor
  • Cell Proliferation
  • Humans
  • Intercellular Signaling Peptides and Proteins (metabolism)
  • Nerve Tissue Proteins (metabolism)
  • Proliferating Cell Nuclear Antigen (metabolism)
  • Receptors, Immunologic (metabolism)
  • Salivary Gland Neoplasms (pathology)
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: